|Market Cap (Intraday)||15.88B|
|2yr Forward PE||6.94|
Novavax, Inc. Stock, NASDAQ:NVAX
Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola, and Middle East respiratory syndrome. The company was founded in 1987 and is headquartered in Gaithersburg, MD.